It’s no secret that the only cannabis available for official use on research is provided by the University of Mississippi and NIDA, which is notoriously low in quality. The lawsuit also states that this marijuana is unfit for research because of “poor quality, unstable supply, and limited variability that in no way emulates the types of cannabis currently available through either state-regulated markets or informal markets where regulated supply is unavailable.” What makes it worse is that this cannabis is only allowed for research and not to be sold commercially, which means that it can’t be used for Phase 3 studies of the FDA, required under the Good Manufacturing Processes.
President Donald Trump has reignited the debate over cannabis policy in Washington, D.C., by linking…
Pink-Runtz has solidified its status as a designer strain worth mastering. This 50% India, 50%…
Find the best THCA strains to smoke this 420 and beyond. Leafly reviewed popular THCA…
A fascinating new study published in the Journal of Hand Surgery Global Online has revealed…
The transfer of The Hawthorne Collective to a strategic partner was made in exchange for…
A vape cartridge is essentially the most important feature of any vape pen. The cart…